Sara Masmoudi, general manager at Teriak, one of Tunisia’s top three pharmaceutical companies, sums up the evolution the company has undergone since she took over its direction in 2003 at age 32. She also talks about the recent acquisition Teriak has made of Cinpharm, a Cameroonian manufacturer, in line with its internationalisation strategy and presents some of the company’s goals for the future: a focus on exportation and the duality between its licencing activity and production of own products.
Ms. Masmoudi, could you please introduce Teriak and its activities to our readers?
"Our biggest bet to date was putting in place a strategy that would see us become an international company."
